✦ LIBER ✦

Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring

✍ Scribed by Au, W-Y; Chan, E C; Pang, A; Lie, A K W; Liang, R; Yuen, A P W; Shek, T W H; Kwong, Y-L

Book ID: 110014334
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 151 KB
Volume: 34
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Jaundice after allogeneic hematopoietic

Jaundice after allogeneic hematopoietic stem cell transplantation

✍ Manuel Mendizabal; Terina Chen; K. Rajender Reddy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

A 43-year-old man with acute lymphoblastic leukemia was treated with three cycles of hyper-CVAD (hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) followed by allogeneic hematopoietic stem cell transplantation (HCT) from a sibling. Six months later, the patient presen

Molecular monitoring of viral infections

Molecular monitoring of viral infections after hematopoietic stem cell transplantation

✍ Per Ljungman 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 166 KB

Second solid cancers after allogeneic he

Second solid cancers after allogeneic hematopoietic stem cell transplantation

✍ Genevieve Gallagher; Donna L. Forrest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Pulmonary dysfunction in survivors of ch

Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation

✍ Hiroto Inaba; Jie Yang; Jianmin Pan; Dennis C. Stokes; Matthew J. Krasin; Ashok 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Hemolytic uremic syndrome after allogene

Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies

✍ Kondo, M; Kojima, S; Horibe, K; Kato, K; Matsuyama, T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Monitoring of WT1-specific cytotoxic T l

Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation

✍ Yuriko Morita; Yuji Heike; Mami Kawakami; Osamu Miura; Shin-ichi Nakatsuka; Mich 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 791 KB

## Abstract Donor‐derived cytotoxic T lymphocytes (CTL) that respond to tumor antigens emerge after hematopoietic stem cell transplantation (HSCT), particularly in association with the status of immune recovery. To analyze the frequency of CTL against PR1, PRAME and WT1 after HSCT, a tetramer‐based